Market is expected to reach USD 7.85 billion by 2031, registering a compound annual growth rate (CAGR) of 5.2% during the forecast period (2025–2032)

Market is expected to reach USD 923.4 million by 2032, registering a compound annual growth rate (CAGR) of 6.3% during the forecast period (2025–2032).

Market is expected to reach USD 567.3 million by 2032, registering a compound annual growth rate (CAGR) of 6.4% during the forecast period (2025–2032).

Market is projected to reach USD 2.34 billion by 2032, growing at a 6.2% CAGR during the forecast period

Market is projected to reach USD 1.06 billion by 2031, expanding at a 7.0% CAGR throughout the forecast period.

SARS-CoV-2 Antigen Test Kit market, valued at USD 2.45 billion in 2024, is projected to reach USD 3.12 billion by 2031, growing at a CAGR of 5.1% during the forecast period.

Allergy diagnostic products market was valued at USD 2.68 billion in 2024 and is expected to reach USD 5.02 billion by 2031, exhibiting a strong CAGR of 10.9% during the forecast period (2025–2032).

Market is projected to decline sharply to USD 789 million by 2031, reflecting a compound annual growth rate (CAGR) of -40.3% during the forecast period (2025–2031).

market is poised for significant growth, expanding from USD 433 million in 2024 to an estimated USD 699 million by 2031, reflecting a CAGR of 7.3% during the forecast period (2025–2031).

Market is projected to reach USD 5,156 million by 2031, exhibiting a robust CAGR of 9.4% during the forecast period.